Skip to content
Wholesale trade
KZActiveBIN 160540001790
Plans from 2 000 ₸ a month
No issues with the company
No matches in 18 risk registers, the head or a founder has registry records
To risks

ТОО "SAMRUKMED"

Director
Дарбаев Алишер Ануарович
Incorporated
04.05.2016
Address
Астана пр. АБАЙ, 92/3, кв. 179
Activity
Оптовая торговля широким ассортиментом товаров без какой-либо конкретизации
Taxes for 202513.8M ₸−4% vs 2024Public contracts excl. VAT157.8M ₸ 15 contracts, latest in 2019Employeesот 0 до 5 чел. Малые предприятия
Risk & checksProfileFinancialsManagement & ownersRelations & mentions

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/18
Related-party risks

Found in government registries against the company’s director or founders. They do not affect the company’s own reliability score.

  • FounderДАРБАЕВ АЛИШЕР АНУАРОВИЧ
    Bad-faith public-procurement participant

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses and permits

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "SAMRUKMED"
BIN
160540001790
Legal address
Астана пр. АБАЙ, 92/3, кв. 179
VAT payer
No, deregistered 02.02.2026. Reason: termination of the VAT payer's activity in connection with the transition from the generally established taxation procedure to a special tax regime
КАТО
711410000
РНН
620200516852
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 0 до 5 чел.

Has changed

Procurement role
Поставщик

Activities

46909 Оптовая торговля широким ассортиментом товаров без какой-либо конкретизации

1
46909primary

Оптовая торговля широким ассортиментом товаров без какой-либо конкретизации

Download

Contacts

Change history

Financials

Tax payments

6
13.8M ₸in 2025, −4% vs 2024
By year · ₸
  1. 2021, partial: 298.6K ₸
  2. 2022: 4.6M ₸
  3. 2023: 5.2M ₸
  4. 2024: 14.4M ₸
  5. 2025: 13.8M ₸
  6. 2026, partial: 22.9M ₸
  1. 2021, partial: 298.6K ₸
  2. 2022: 4.6M ₸
  3. 2023: 5.2M ₸
  4. 2024: 14.4M ₸
  5. 2025: 13.8M ₸
  6. 2026, partial: 22.9M ₸
Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

1
  • ДА

    Дарбаев Алишер Ануарович

    Director

Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "SAMRUKMED" (BIN 160540001790) is an active legal entity, registered in 2016, located in Astana, 10 years on the market. Primary classifier activity: wholesale trade. Small enterprise, headcount: up to 5 employees. 13.8M ₸ in taxes was paid in 2025 (per the tax authority as of October 25, 2026). Public procurement: 15 contracts as a supplier, total value 157.8M ₸; the latest contract was signed in 2019. Automated screening of open registries found no risk indicators for «SAMRUKMED». The latest change to registration data: change of address (June 1, 2022). Number of founders: 1. Head per the registry: Дарбаев Алишер Ануарович. Registry snapshot dated June 11, 2026.

Data sources and disclaimer

Sources: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is collected automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the fact. This is reference information and does not replace an official extract. Methodology: SafeDeal editorial policy.